Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Budget Impact Analysis of Intensification with iGlarLixi Compared to Alternative Treatment Strategies Among Patients with Type 2 Diabetes Mellitus.
Diabetes Ther. 2023 Dec;14(12):2109-2125. doi: 10.1007/s13300-023-01477-3. Epub 2023 Oct 6.
Diabetes Ther. 2023.
PMID: 37801225
Free PMC article.
Clinical Benefits of Treating Patients with Type 2 Diabetes Mellitus with iGlarLixi: A Patient-Level Simulation Study.
Chauhan A, Samnaliev M, Ken-Opurum J, Srinivas SSS, Mehta AM, Dex T, Charland S, Revel A, Preblick R.
Chauhan A, et al. Among authors: srinivas sss.
Diabetes Ther. 2023 Aug;14(8):1331-1344. doi: 10.1007/s13300-023-01419-z. Epub 2023 Jun 8.
Diabetes Ther. 2023.
PMID: 37289358
Free PMC article.
Item in Clipboard
The economic value of insulin glargine 300 U/mL (Gla-300) in people ≥18 years of age with type 2 diabetes mellitus: a value-based economic model from a U.S. payer perspective.
Ponomareva E, Schmerold L, Sss S, Preblick R, Park S, Wilson L, Revel A.
Ponomareva E, et al. Among authors: sss s.
J Med Econ. 2023 Jan-Dec;26(1):1469-1478. doi: 10.1080/13696998.2023.2277058. Epub 2023 Nov 11.
J Med Econ. 2023.
PMID: 37916295
Free article.
Item in Clipboard
Cite
Cite